Kolb EA - Search Results

1

Retraction: Integrating mechanisms of response and resistance against the tubulin binding agent Eribulin in preclinical models of osteosarcoma.

Sampson VB, Vetter NS, Zhang W, Patil PU, Mason RW, George E, Gorlick R, Kolb EA. Sampson VB, et al. Among authors: kolb ea. Oncotarget. 2024 Oct 11;15:725. doi: 10.18632/oncotarget.28663. Oncotarget. 2024. PMID: 39392376 Free PMC article. No abstract available.

2

Integrating mechanisms of response and resistance against the tubulin binding agent Eribulin in preclinical models of osteosarcoma.

Sampson VB, Vetter NS, Zhang W, Patil PU, Mason RW, George E, Gorlick R, Kolb EA. Sampson VB, et al. Among authors: kolb ea. Oncotarget. 2016 Dec 27;7(52):86594-86607. doi: 10.18632/oncotarget.13358. Oncotarget. 2016. Retraction in: Oncotarget. 2024 Oct 11;15:725. doi: 10.18632/oncotarget.28663 PMID: 27863409 Free PMC article. Retracted.

3

Development of IGF-IR Inhibitors in Pediatric Sarcomas.

Kolb EA, Gorlick R. Kolb EA, et al. Curr Oncol Rep. 2009 Jul;11(4):307-13. doi: 10.1007/s11912-009-0043-1. Curr Oncol Rep. 2009. PMID: 19508836 Review.

4

Initial testing (stage 1) of eribulin, a novel tubulin binding agent, by the pediatric preclinical testing program.

Kolb EA, Gorlick R, Reynolds CP, Kang MH, Carol H, Lock R, Keir ST, Maris JM, Billups CA, Desjardins C, Kurmasheva RT, Houghton PJ, Smith MA. Kolb EA, et al. Pediatr Blood Cancer. 2013 Aug;60(8):1325-32. doi: 10.1002/pbc.24517. Epub 2013 Mar 28. Pediatr Blood Cancer. 2013. PMID: 23553917 Free PMC article.

5

Xenograft and genetically engineered mouse model systems of osteosarcoma and Ewing's sarcoma: tumor models for cancer drug discovery.

Sampson VB, Kamara DF, Kolb EA. Sampson VB, et al. Among authors: kolb ea. Expert Opin Drug Discov. 2013 Oct;8(10):1181-9. doi: 10.1517/17460441.2013.817988. Epub 2013 Jul 12. Expert Opin Drug Discov. 2013. PMID: 23844615 Free PMC article. Review.

6

Initial testing (stage 1) of BAL101553, a novel tubulin binding agent, by the pediatric preclinical testing program.

Kolb EA, Gorlick R, Keir ST, Maris JM, Kang MH, Reynolds CP, Lock RB, Carol H, Wu J, Kurmasheva RT, Houghton PJ, Smith MA. Kolb EA, et al. Pediatr Blood Cancer. 2015 Jun;62(6):1106-9. doi: 10.1002/pbc.25329. Epub 2014 Nov 18. Pediatr Blood Cancer. 2015. PMID: 25407467 Free PMC article.

7

MicroRNAs and Potential Targets in Osteosarcoma: Review.

Sampson VB, Yoo S, Kumar A, Vetter NS, Kolb EA. Sampson VB, et al. Among authors: kolb ea. Front Pediatr. 2015 Aug 24;3:69. doi: 10.3389/fped.2015.00069. eCollection 2015. Front Pediatr. 2015. PMID: 26380245 Free PMC article. Review.

8

The Microtubule Network and Cell Death Are Regulated by an miR-34a/Stathmin 1/βIII-Tubulin Axis.

Vetter NS, Kolb EA, Mills CC, Sampson VB. Vetter NS, et al. Among authors: kolb ea. Mol Cancer Res. 2017 Jul;15(7):953-964. doi: 10.1158/1541-7786.MCR-16-0372. Epub 2017 Mar 8. Mol Cancer Res. 2017. PMID: 28275089 Free PMC article.

9

Recent Advances of Cell-Cycle Inhibitor Therapies for Pediatric Cancer.

Mills CC, Kolb EA, Sampson VB. Mills CC, et al. Among authors: kolb ea. Cancer Res. 2017 Dec 1;77(23):6489-6498. doi: 10.1158/0008-5472.CAN-17-2066. Epub 2017 Nov 2. Cancer Res. 2017. PMID: 29097609 Free PMC article. Review.

10

Development of Chemotherapy with Cell-Cycle Inhibitors for Adult and Pediatric Cancer Therapy.

Mills CC, Kolb EA, Sampson VB. Mills CC, et al. Among authors: kolb ea. Cancer Res. 2018 Jan 15;78(2):320-325. doi: 10.1158/0008-5472.CAN-17-2782. Epub 2018 Jan 8. Cancer Res. 2018. PMID: 29311160 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

223 results

Search Page

Filters